Jubilant DraxImage Inc.
2 clinical trials · Sponsor
◉ Watch Jubilant DraxImage Inc.
| Record | Firm | Date |
|---|---|---|
| A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects (NCT03561259) | Jubilant DraxImage Inc. | 2019-10-21 |
Track Jubilant DraxImage Inc. automatically
Every clearance here is in the API, with alerts when new ones post.